Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
UHN-invented MolecuLight Inc. achieved a major regulatory milestone permitting expansion into the United States market.
The U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the groundbreaking wound fluorescence imaging device, the MolecuLight
Developed by Dr. Ralph DaCosta, Molecular Imaging Scientist at Princess Margaret Cancer Centre and Techna Institute, UHN, the device digitally captures and documents fluorescence information from wounds and surrounding tissue using still images and videos in real-time.
i:X platform is a significant advancement in the management of chronic wounds, that is already revolutionizing wound care practice in Canada and Europe," says Dr. DaCosta, Founder, Chief Scientific Officer and Director of MolecuLight Inc.
Chronic wounds resulting from hospital-acquired infections, an epidemic of diabetes and the increasingly complex health issues of an aging population, are a growing burden on patients, healthcare providers and healthcare systems.
"Thousands of patients to date have already experienced a change in their assessment and treatment by clinicians who feel empowered by the wound fluorescence images they are seeing. As reported in multi-centered published clinical studies, clinicians used the images to inform their wound management practices in real-time, in particular, for guided wound sampling, cleaning and debridement," Dr. DaCosta says.
"We're very excited that U.S. clinicians will soon have the same access to this device as their peers in Canada and Europe.''
Fire Marshals at TG evacuate inpatient transplant unit
The transplant inpatient unit on 7A at Toronto General Hospital (TG) exceeded all standards during UHN's annual fire drill with Toronto Fire Services last month.
Fire Marshal Perry Ross says the six staff in the unit who were involved in the drill had 75 minutes to evacuate 11 mock patients, but they were able to complete the drill in just nine minutes.
With exceptional teamwork and guidance from the TG fire marshals, the staff on the unit safely evacuated the mock patients to an area on the floor where they would be safe from a potential fire.
"We test out emergency preparedness in the event of a real fire situation – the ability for us to evacuate the floor in a timely manner is extremely important," Perry says.
Volunteers from Volunteer Resources simulated patients in the unit during the drill, which Toronto Fire Services must oversee at every hospital once a year.